General Information
Revision date
2013-02-20
Product name
Estradiol valerate
CAS No.
979-32-8
1.2.1 Relevant identified uses
Pharma Active ingredients
1.2.2. Uses advised against
No further relevant information available
Icons in SDS
Company Information
company name
Fagron UK Ltd
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H351, H360, H362, H413
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
CLP CLASSIFICATION
GHS08 health hazard Carc. 2 H351 Suspected of causing cancer. Repr. 1A H 3 6 0 - May damage fertility or the unborn child. May cause harm to breast-fed children. H362 Aquatic Chronic 4H413 May cause long lasting harmful effects to aquatic life.
EU Classification
Directive 67/548/EEC or Directive 1999/45/EC T; Toxic Repr. Cat. 1, 3 R60: May impair fertility. Xn; Harmful R40-63: Limited evidence of a carcinogenic effect. Possible risk of harm to the unborn child. R53-64: May cause long-term adverse effects in the aquatic environment. May cause harm to breastfed Carc. Cat. 3 babies. · Information concerning particular hazards for human and environment: Not applicable.
2.2 Label elements
Labelling according to Regulation (EC) No 1272/2008 The substance is classified and labelled according to the CLP regulation.
Hazard pictograms
GHS08
Signal word
Danger
Hazard statements
H351 Suspected of causing cancer. H360-H362 May damage fertility or the unborn child. May cause harm to breast-fed children. H413 May cause long lasting harmful effects to aquatic life.
Precautionary statements
P263 Avoid contact during pregnancy/while nursing. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P281 Use personal protective equipment as required. P273 Avoid release to the environment. P405 Store locked up. P501 Dispose of contents/container in accordance with local/regional/national/international regulations.
PBT Substances
Not applicable
vPvB Substances
Not applicable *
